Skip to content
PoliticalRepoPoliticalRepo

United States · Bill · S

S. 303 (104th)

Biomaterials Access Assurance Act of 1995

referredUnited States· United States Congress· EN

Introduced

31 January 1995

Last action

31 January 1995 · Introduced

Status

Read twice and referred to the Committee on Commerce.

Sponsors

Sen. Lieberman, Joseph I. [ID-CT], Sen. McCain, John [R-AZ], Sen. Bradley, Bill [D-NJ], Sen. Brown, Hank [R-CO], Sen. Coats, Daniel [R-IN], Sen. Kyl, Jon [R-AZ], Sen. McConnell, Mitch [R-KY], Sen. Gregg, Judd [R-NH], Sen. Inouye, Daniel K. [D-HI], Sen. Lugar, Richard G. [R-IN], Sen. Grassley, Chuck [R-IA], Sen. Inhofe, James M. [R-OK], Sen. Grams, Rod [R-MN], Sen. Lott, Trent [R-MS], Sen. Frist, William H. [R-TN], Sen. Pressler, Larry [R-SD]

Subjects

Defence

Source updated

21 August 2025

Defence

Summary

Biomaterials Access Assurance Act of 1995 - Provides that, in any civil action, a biomaterials supplier (one who supplies components or raw materials used to manufacture implants) may raise any defense provided under this Act. Exempts a biomaterials supplier (supplier) from liability for harm to a claimant caused by an implant, with exceptions in the case of a supplier who: (1) is a registered manufacturer of the implant; (2) is a seller of the implant and who held title to the implant at the time of sale; or (3) furnishes raw materials or components that fail to meet applicable contractual requirements or specifications. Provides grounds for liability with respect to each exception. Outlines procedural guidelines for the dismissal of civil actions against suppliers, including the submission of appropriate affidavits in support of, or in defense to, a claim. States that a supplier may be considered a manufacturer of an implant, for purposes of such civil actions, only if the supplier has registered with the Secretary of Health and Human Services and included the implant on a list of devices filed pursuant to the Federal Food, Drug, and Cosmetic Act. Requires claimant payment of attorney's fees if the court finds the claim to be without merit and frivolous.

This text is taken from the official record. PoliticalRepo does not editorialize.

Timeline

  1. 31 January 1995

    Introduced

    Read twice and referred to the Committee on Commerce.

    Source: IntroReferral

  2. 31 January 1995

    Introduced

    Sponsor introductory remarks on measure. (CR S1853-1854)

    Source: IntroReferral

  3. 31 January 1995

    Introduced

    Introduced in Senate

    Source: IntroReferral

Votes

No vote records are attached yet.

Versions

Documents

3 official files

Introduced in Senate (text)

View fileDownload file

This file cannot be previewed here. Use View or Download.

Leesvertaling

Vertaal dit document naar jouw taal. PoliticalRepo bewaart geen aparte kopie per EU-taal.

Documentvertaling op verzoek met downloadbare PDF (logo + link naar de officiële bron). Het bronbestand blijft leidend.

  • Introduced in Senate (text)

    Introduced in Senate · EN · 31 January 1995

    ViewDownloadOpen at official source

  • Introduced in Senate (PDF)

    Introduced in Senate · EN · 31 January 1995

    ViewDownloadOpen at official source

    Leesvertaling

    Vertaal dit document naar jouw taal. PoliticalRepo bewaart geen aparte kopie per EU-taal.

    Documentvertaling op verzoek met downloadbare PDF (logo + link naar de officiële bron). Het bronbestand blijft leidend.

  • Introduced in Senate

    summary · EN · 31 January 1995

    Open at official source

    Leesvertaling

    Vertaal dit document naar jouw taal. PoliticalRepo bewaart geen aparte kopie per EU-taal.

    Documentvertaling op verzoek met downloadbare PDF (logo + link naar de officiële bron). Het bronbestand blijft leidend.

Sponsors

Related records

Sources

PoliticalRepo is an index and interpretation layer, not the authoritative legal source.